Healthcare and Life Science
Why 454 million people are waiting for a device already in their pocket
The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes EverythingHere's an uncomfortable truth: we've had the technology to transform respiratory diagnostics for years. It's sitting in your pocket right now. ...
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026...
From speed to proof: what happens when innovation meets system maturity
For many founders, the early phase of innovation is familiar territory. A strong idea gains traction, early pilots show promise, and momentum builds around speed — speed to prototype, speed to market, speed to scale. ...
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in AsiaSystem strengthens Taiwan’s capabilities in protein drug discovery researchCambridge, UK, and Boston MA, USA, 07 January 2026: Nuclera, the...
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies ...
Royal College Fellowship joy for three CPFT psychiatrists
Three psychiatrists at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have been awarded prestigious Fellowships by the Royal College of Psychiatrists, honouring their outstanding contributions to mental health care and research. ...
University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare
The University of Cambridge, AstraZeneca and Beijing municipal parties (the Beijing Science and Technology Commission and the Beijing Economic and Technological Development Area), have signed an agreement that will enhance collaboration between the University, AstraZeneca and Cambridge ...
Why gene therapy matters now
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new situation review on the FDA approved "classical" gene therapy landscape. ...
Share your views - The Institute for Biomedical Innovation (IBI)
The Institute for Biomedical Innovation (IBI) is a new major investment by the University of Cambridge. Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices. It will combine a state-of-the-art prot...
UK CFOs upbeat on tech investment and potential for AI to boost productivity for year ahead
More than half of finance chiefs (59%) have become more optimistic over the past 12 months on the potential for AI to boost the performance of their organisation, up from 39% in Q3 of 2024; Almost all of them (96%) expect to see a rise in investment in digital technology and asse...